Extracorporeal Membrane Oxygenation
76
16
20
27
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
2 terminated out of 76 trials
93.1%
+6.5% vs benchmark
5%
4 trials in Phase 3/4
7%
2 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 27 completed trials
Clinical Trials (76)
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
Personalized Ventilator Settings for Patients on ECMO
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
Feasibility of Protocolised Analgosedation in ECMO
ECMO Treatment of Children in China in the Past 10 Years
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Evaluation of Membrane Lung Function in High-altitude Regions
Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation
Reduced Anticoagulation Targets in ECLS (RATE)
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO
HRQOL of Life After ECMO Due to COVID-19.
Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients